Skip to main content
Clinical Trials/NCT02591394
NCT02591394TerminatedNot Applicable

STEPs to Blood Pressure Reduction. A Randomized Clinical Trial of the Stroke Transitions, Education, and Prevention Clinic Versus Usual Care for Post-Stroke Blood Pressure Reduction

The University of Texas Health Science Center, Houston1 site in 1 country115 target enrollmentStarted: November 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
115
Locations
1
Primary Endpoint
Daytime ambulatory systolic blood pressure

Study Overview

Brief Summary

The Stroke Transitions Education and Prevention (STEP) Clinic is a new type of clinic designed for stroke patients and was established to provide a comprehensive approach to stroke risk factor reduction. The goal of this study will be more effective than usual care at reducing blood pressure in patients with poorly controlled blood pressure after an ischemic or hemorrhagic stroke or transient ischemic attack.

Detailed Description

STEP clinic patients will receive personalized goals, instructions to self-monitor, a blood pressure monitor, prescription medications, sleep apnea screening, dietary counseling, and more frequent follow-up if needed. A stroke neurologist will see patients in the usual care group and recommendations will be sent to their primary care providers.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Clinical ischemic stroke, intracerebral hemorrhage, or transient ischemic attack
  • •Plan to discharge home or to short stay inpatient rehab after stroke
  • •Two of following required:
  • •History of hypertension (prior to hospitalization)
  • •Hospital blood pressure ≥ 140/90 on two or more occasions during hospitalization
  • •Discharge home on blood pressure medication
  • •Willingness and ability to follow-up in University of Texas Physicians stroke clinic

Exclusion Criteria

  • •Modified Rankin scale (mRs) > 3 at enrollment
  • •Terminal illness
  • •Chronic kidney disease stage 4 or greater (eGFR < 30)
  • •Pregnancy
  • •Symptomatic flow limiting carotid stenosis without plan for intervention prior to clinic visit
  • •Stroke etiology presumed unrelated to atherosclerotic risk factors (amyloid angiopathy, vasculitis, malignancy associated)

Arms & Interventions

STEP Clinic

Experimental

Intervention: STEP Clinic (Behavioral)

Usual Care

Active Comparator

Intervention: Usual Care (Behavioral)

Outcomes

Primary Outcomes

Daytime ambulatory systolic blood pressure

Time Frame: 6 months

Secondary Outcomes

  • Daytime ambulatory diastolic blood pressure(6 months)
  • Number of patient monitoring blood pressure at home(6 months)
  • Number of patients achieving blood pressure control at 6 months as assessed by ambulatory blood pressure(6 months)
  • Number of patients achieving blood pressure control at 6 months as assessed by automated office blood pressure(6 months)
  • Nighttime ambulatory systolic blood pressure(6 months)
  • Nighttime ambulatory diastolic c blood pressure(6 months)
  • Depressive Symptoms as assessed by Patient Health Questionnaire 9(6 months)
  • Satisfactions with stroke clinic as assessed by Consumer Assessment of Healthcare Providers and Systems Survey(6 months)
  • Number of participants who are adherent to blood pressure medications(6 months)
  • Satisfaction with Social Roles and activities as measured by NeuroQuality of Life short form(6 months)
  • Self Efficacy as Assessed by Medication Adherence Self-Efficacy Scale(6 months)
  • Number of composite cardiovascular events(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Anjail Z Sharrief

Assistant Professor of Neurology

The University of Texas Health Science Center, Houston

Study Sites (1)

Loading locations...

Similar Trials